News
Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...
2d
News-Medical.Net on MSNShingles and RSV vaccines with AS01 adjuvant reduce dementia riskResearchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...
A different 2021 study found that treating the eye conditions increasing a person’s risk of dementia could actually reverse ...
Maintaining brain health is just as important as caring for our bodies, especially as we grow older. Keeping the brain in ...
2d
Study Finds on MSNThese U.S. Regions Have Higher Dementia Rates — Are You at Risk?Dementia rates vary dramatically across U.S. regions in ways that can't be explained by age, education, or health conditions.
Two healthy-ageing experts say interventions could result in both delayed disease onset and improved quality of life for ...
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results